Researchers at the National Institutes of Health and their colleagues at health centers in the District of Columbia discuss clinical studies aimed at improving hepatitis C treatments. The studies, which focus on hard-to-treat patients, such as those who also have HIV, are conducted through the DC Partnership for HIV/AIDS Progress, a program sponsored by NIH and the DC Department of Health.